tailieunhanh - The perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: A UK regional audit of practice

Biologic drugs are expensive treatments used in rheumatoid arthritis (RA). Switching among them is common practice in patients who have had an inadequate response or intolerable adverse events. The National Institute of Health and Clinical Excellence (NICE) UK, which aims to curtail postcode prescribing, has provided guidance on the sequential prescription of these drugs. |